Zai Lab Ltd ZLAB.OQ, ZLAB.O is expected to show a rise in quarterly revenue when it reports results for the period ending June 30 2025
The Shanghai-based company is expected to report a 24.4% increase in revenue to $125.013 million from $100.5 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for Zai Lab Ltd is for a loss of 41 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Zai Lab Ltd is $55.00, about 30.8% above its last closing price of $38.05
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.54 | -0.55 | -0.40 | Beat | 27.1 |
Dec. 31 2025 | -0.65 | -0.65 | -0.80 | Missed | -22.8 |
Sep. 30 2024 | -0.77 | -0.78 | -0.42 | Beat | 46.3 |
Jun. 30 2024 | -0.70 | -0.71 | -0.80 | Missed | -13 |
Mar. 31 2024 | -0.93 | -0.92 | -0.50 | Beat | 45.9 |
Dec. 31 2023 | -0.87 | -0.86 | -1.00 | Missed | -16.8 |
Sep. 30 2023 | -1.11 | -1.04 | -0.71 | Beat | 32 |
Jun. 30 2023 | -0.80 | -0.79 | -1.25 | Missed | -58.4 |
This summary was machine generated August 5 at 13:39 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。